Biotechnology News

June 24, 2014

SAINT-PREX & ROTKREUZ, Switzerland--(BUSINESS WIRE)--Ferring’s follicle-stimulating hormone is in development with a companion diagnostic test from Roche to help improve the clinical management of infertility treatment

June 24, 2014

SAN DIEGO--(BUSINESS WIRE)--Ligand Pharmaceuticals Incorporated (NASDAQ:LGND) announced the signing of an exclusive global license agreement with TG Therapeutics, Inc. (NASDAQ: TGTX) for the development and commercialization of Ligand’s...

June 24, 2014

CAMBRIDGE, Mass.--(BUSINESS WIRE)--Mersana and Merck KGaA have entered a collaboration to create antibody-drug conjugates using Mersana's Fleximer-ADC platform, which provides Merck KGaA the opportunity to expand its oncology pipeline.

June 24, 2014

VELIZY-VILLACOUBLAY, France--(BUSINESS WIRE)--Dassault Systèmes (Euronext Paris: #13065, DSY.PA), the 3DEXPERIENCE Company, world leader in 3D design software, 3D Digital Mock Up and Product Lifecycle Management (PLM) solutions, announced today...

June 24, 2014

DUBLIN, Ireland--(BUSINESS WIRE)--Covidien announced the European launch of its Pipeline™ Flex embolization device at the annual Live Interventional Neuroradiology & Neurosurgery Course (LINNC), held in Paris June 23-25.

June 23, 2014

SAN DIEGO--(BUSINESS WIRE)--The Biotechnology Industry Organization (BIO) is pleased to announce the re-election of Rachel King, President & CEO, GlycoMimetics, Inc., as the Chair of its Board of Directors for the 2014-2015 term, the election...

June 23, 2014

WHITEHOUSE STATION, N.J.--(BUSINESS WIRE)--Merck will hold its second-quarter 2014 sales and earnings conference call with institutional investors and analysts at 8:00 a.m. EDT on Tuesday, July 29.

June 23, 2014

SAN DIEGO--(BUSINESS WIRE)--Ligand Pharmaceuticals Incorporated (NASDAQ: LGND) today announced that it will participate in the ROTH Capital Partners’ Healthcare Corporate Access Day to be held on Tuesday, June 24, 2014 in London. The event...

June 23, 2014

CAMBRIDGE, Mass.--(BUSINESS WIRE)--As a result of an in-depth review of the company’s research & development portfolio, InVivo Therapeutics has announced that the company is realigning resources behind its novel Neuro-Spinal Scaffold and the...

June 23, 2014

VALLEY FORGE, Pa.--(BUSINESS WIRE)--AmerisourceBergen Corporation (NYSE:ABC) (the “Company”) today announced the completion of the redemption of all outstanding aggregate principal amount of its 5 7/8% Senior Notes due 2015 (CUSIP 03073EAF2 and...

June 23, 2014

SAN DIEGO--(BUSINESS WIRE)--The 2014 BIO International Convention, the world’s largest biotechnology event, kicks off today in the San Diego Convention Center and goes through Thursday, June 26.

June 23, 2014

COPPELL, Texas--(BUSINESS WIRE)--ZS Pharma, Inc., a biopharmaceutical company developing novel treatments for kidney, cardiovascular, liver and metabolic disorders, today announced the closing of its initial public offering of 6,836,111 shares of...

June 23, 2014

CLEVELAND--(BUSINESS WIRE)--The Ohio Clinical Trials Collaborative (OCTC) holds market launch at BIO2014 in San Diego, providing pharmaceutical and medical device companies centralized access to Ohio’s premier medical schools and affiliated...

June 23, 2014

SAN DIEGO--(BUSINESS WIRE)--Organizations from Saskatchewan, Canada Showcase Award-Winning Research and Development at BIO International Convention – June 24-26 – San Diego, CA

June 23, 2014

--(BUSINESS WIRE)--2014 BIO International Convention: a panel of four U.S. Governors to discuss policies and programs that accelerate the growth of biotech and a new Battelle/BIO State Bioscience Jobs report.

June 23, 2014

RESEARCH TRIANGLE PARK, N.C.--(BUSINESS WIRE)--Press Kit Materials are Available at:...

June 23, 2014

PARIS--(BUSINESS WIRE)--Cellectis’ UCART19 receives Advanced-Therapy medicinal Product classification from EMA

June 23, 2014

CHICAGO--(BUSINESS WIRE)--LAUNCHED TODAY: 2014 JLL Global Life Sciences Cluster Report, tracking global biotech investment geographic
shifts. Access report, releases, images, multimedia, onsite PR, Wed. 6/25 news conf. info.

June 23, 2014

--(BUSINESS WIRE)--Assistant Secretary of the Navy Dennis McGinn will discuss biofuels and national security, hold a media availability with reporters, during BIO International Convention in San Diego.

June 23, 2014

LEXINGTON, Mass.--(BUSINESS WIRE)--Clinical Chemistry Study Reports on Use of T2MR to Evaluate Hemostasis in Whole Blood

June 23, 2014

PLANO, Texas--(BUSINESS WIRE)--Neuro Resource Group's InterX 900 ISSDE pain management system hospital use expands helping to improve patient outcomes and lower cost.

June 23, 2014

FREISING, Germany--(BUSINESS WIRE)--Pieris AG announced that it has achieved a second milestone for its second program, and fifth milestone overall, in its discovery and development collaboration with Daiichi Sankyo Company Limited (hereinafter...

June 23, 2014

MELBOURN, England--(BUSINESS WIRE)--TTP Labtech, an employee-owned life science company based near Cambridge, UK, has reported an impressive 43% increase in revenues and an associated increase in profits over 2013.

June 23, 2014

OSLO, Norway--(BUSINESS WIRE)--Reference is made to the announcement made on 18 June 2014 regarding the successful completion of the Company’s MUSD 41.6 (NOK 250 million) pre-IPO private placement. The Board of Directors has resolved to call for...

June 23, 2014

DENVER--(BUSINESS WIRE)--Colorado BioScience Association (CBSA) is releasing its annual edition of Bioscience Colorado, this week, at the BIO International Convention in San Diego, CA.

June 23, 2014

WATERTOWN, Mass.--(BUSINESS WIRE)--Syros Pharmaceuticals Co-Founders' Novel Approach to Cancer Regulation is Published in Nature. The discovery further validates Syros' proprietary gene control platform.

June 23, 2014

WASHINGTON--(BUSINESS WIRE)--MIT H@cking Medicine is pleased to announce a four hour Digital Design Idea Hackathon, on Thursday morning, June 26 in conjunction with the 2014 BIO International Convention® in San Diego, CA.

June 23, 2014

CAMBRIDGE, Mass.--(BUSINESS WIRE)--OvaScience to Present at the 2014 BIO International Convention

June 23, 2014

DUBLIN & NEW YORK--(BUSINESS WIRE)--Actavis plc (NYSE:ACT) and Forest Laboratories, Inc. (NYSE:FRX) today announced that C. David Nicholson, PhD will be appointed Senior Vice President, Actavis Global Brands R&D following the close of...

June 23, 2014

SANTA CLARA, Calif.--(BUSINESS WIRE)--XenoPort, Inc. (Nasdaq: XNPT) announced today that it has initiated a Phase 2 clinical trial of XP23829, its proprietary investigational next-generation fumaric acid product candidate. The trial is a multi-...

June 23, 2014

SAN JOSE, Calif. & HERTZELIA, Israel--(BUSINESS WIRE)--The Personalized Medicine World Conference announced that Dr. Michael Hayden, President and Chief Scientific Officer of Teva Pharmaceuticals, is the recipient of the 2014 PMWC Luminary...

June 23, 2014

IRVINE, Calif.--(BUSINESS WIRE)--Allergan, Inc. (NYSE: AGN) (“Allergan” or the “Company”) today announced that its Board of Directors, after consultation with its independent financial and legal advisors, unanimously determined that Valeant...

June 23, 2014

RESEARCH TRIANGLE PARK, N.C.--(BUSINESS WIRE)--Quintiles has been named one of IDG Computerworld's 100 Best Places to Work in IT 2014.

June 23, 2014

WHITEHOUSE STATION, N.J.--(BUSINESS WIRE)--Merck today announced the future appointment of Michael J. Holston as general counsel, effective July 01, 2015. Holston will succeed Bruce N. Kuhlik upon his retirement.

June 23, 2014

WALTHAM, Mass.--(BUSINESS WIRE)--PerkinElmer, Inc., a global leader focused on the health and safety of people and the environment, today announced the launch of the new EnSight™ Multimode Plate Reader. The EnSight system is the first plate...

June 23, 2014

CAMBRIDGE, Mass.--(BUSINESS WIRE)--Genocea announces positive top-line phase 1 results for novel universal pneumococcus vaccine candidate. GEN-004 met its safety, tolerability and immunogenicity goals.

June 23, 2014

SURESNES, France & BOULDER, Colo.--(BUSINESS WIRE)--Servier and miRagen extend research collaboration to develop microRNA (miRNA)-targeting therapeutics for the treatment of patients suffering from cardiovascular diseases.

June 23, 2014

CLEVELAND & NEW YORK--(BUSINESS WIRE)--Juventas Therapeutics, Inc., a private clinical-stage company developing a drug-based approach to regenerative medicine, presenting at JMP Securities 2014 Healthcare Conference

June 23, 2014

ALISO VIEJO, Calif. & WILMINGTON, Mass.--(BUSINESS WIRE)--Ambry Genetics and Kapa Biosystems announced that Ambry Genetics has selected the KAPA Hyper Prep Kits for its new ExomeNext and ExomeNext – Rapid tests.

June 23, 2014

SAN DIEGO--(BUSINESS WIRE)--Ligand Pharmaceuticals Incorporated (NASDAQ: LGND) announced that data from a Phase 1 study of the selective estrogen receptor modulator (SERM) lasofoxifene were featured in a poster presentation today at ICE/ENDO 2014...

June 23, 2014

CAMBRIDGE, Mass.--(BUSINESS WIRE)--ARIAD Pharmaceuticals, Inc. (NASDAQ:ARIA) today announced the recent appointments of three executives with extensive pharmaceutical industry experience in the areas of global quality, medical affairs, and drug...

June 23, 2014

NEW YORK--(BUSINESS WIRE)--Enzo Biochem, Inc. (NYSE:ENZ) (the "Company"), along with its subsidiary Enzo Life Sciences, Inc. entered into a Settlement with PerkinElmer, Inc. and PerkinElmer Health Sciences, Inc. (NYSE:PKI) with respect to an...

June 23, 2014

ZUG, Switzerland--(BUSINESS WIRE)--PSI CRO, a full-service contract research organization, announced today that Kasia Moscicka, Director Feasibility Research and Patient Recruitment Services, presented on the changing dynamic of clinical trial...

June 23, 2014

NEW YORK--(BUSINESS WIRE)--Actinium Pharmaceuticals, Inc. (NYSE MKT:ATNM) (“Actinium” or “the Company”), a biopharmaceutical company developing innovative targeted payload immunotherapeutics for the treatment of advanced cancers, today announced...

June 23, 2014

JERUSALEM--(BUSINESS WIRE)--BioLineRx In-Licenses Novel Compound for Treatment of Neuropathic Pain BL-1110 was shown in preclinical studies to enhance analgesic effect of morphine while reducing negative side effects

June 23, 2014

KING OF PRUSSIA, Pa.--(BUSINESS WIRE)--Trevena, Inc. (NASDAQ:TRVN) today announced positive results from its Phase 1 trial of TRV734, which Trevena is developing with the goal of providing improved analgesia while avoiding gastrointestinal and...

June 23, 2014

CHESHIRE, Conn. & CINCINNATI--(BUSINESS WIRE)--Alexion and Cincinnati Children’s Hospital Medical Center announced the establishment of a collaboration and fund for the advancement of research in rare disease.

June 23, 2014

BOULDER, Colo.--(BUSINESS WIRE)--Clovis Oncology Announces First Patient Enrolled in TIGER2 Study of CO-1686

June 23, 2014

CAMBRIDGE, Mass.--(BUSINESS WIRE)--Dimension Therapeutics and Bayer HealthCare Enter Collaboration to Develop Novel Gene Therapy for Hemophilia A